Serotype Diversity and Molecular Characterization of Foot-and-Mouth Disease Viruses From Outbreaks in Ethiopia (2019-2023): Re-Emergence of SAT 2 After 30 Years

埃塞俄比亚(2019-2023 年)口蹄疫疫情中病毒的血清型多样性和分子特征:SAT 2 型在 30 年后再次出现

阅读:1

Abstract

Ethiopia faces significant economic losses from foot-and-mouth disease (FMD). Laboratory diagnostic tools such as antigen detection ELISA (Ag-ELISA), reverse transcription polymerase chain reaction (RT-PCR), and sequencing provide important information that underpin control initiatives. In this study, 411 samples (275 epithelial tissues, 12 oropharyngeal probang cup scrapings and fluids, 122 swab samples, and two whole blood) collected from cattle with clinical signs of FMD were tested to determine serotype diversity of the FMD viruses (FMDVs) present in Ethiopia during a 5-year period (2019-2023). RT-PCR testing showed that most samples, 81.1% (172/212) were positive for FMDV genome while 48.2% (198/411) of the samples were positive for FMDV antigen using ELISA, identifying serotypes O (10.9%), A (7.3%), Southern African Territories (SAT) 1 (1.7%), and SAT 2 (19.5%). Furthermore, evidence for mixed serotype infection was observed for 36 samples using the Ag-ELISA. Viral protein (VP) 1 sequencing for FMDV was performed on 94 samples, confirming the presence of three FMDV serotypes (O, A, and SAT 2). There was no molecular sequence evidence for outbreaks due to SAT 1 during this period, suggesting that the Ag-ELISA results for this serotype may have been false positives. Together with the Ag-ELISA data, the sequences highlighted a dramatic increase in the dominance of serotype SAT 2 viruses during the period of the study, associated with outbreaks due to the emerging SAT2/XIV topotype after a period of absence of more than 30 years. These data highlight Ethiopia's dynamic FMD landscape, informing national and regional control. These findings are crucial for understanding FMDV in Ethiopia and vaccine selection, although more geographically broad and sequencing-intensive studies may be needed to define a more comprehensive understanding of the national disease epidemiology.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。